ArticleThe Journal of antibiotics2017
Identification of tirandamycins as specific inhibitors of the futalosine pathway.
Article in The Journal of antibiotics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- The shikimate pathway: gateway to metabolic diversity.Natural product reports · 2024Review
- Discovery of an alternative pathway of peptidoglycan biosynthesis: A new target for pathway specific inhibitors.Journal of industrial microbiology & biotechnology · 2021Article
- Inhibition of the futalosine pathway for menaquinone biosynthesis suppresses Chlamydia trachomatis infection.FEBS letters · 2021Article
- Identification of pulvomycin as an inhibitor of the futalosine pathway.The Journal of antibiotics · 2021Article
- Engineering P450 TamI as an Iterative Biocatalyst for Selective Late-Stage C-H Functionalization and Epoxidation of Tirandamycin Antibiotics.ACS catalysis · 2021Article
- Bioactive Compounds from Marine Sponges: Fundamentals and Applications.Marine drugs · 2021Review
- The Biological and Chemical Diversity of Tetramic Acid Compounds from Marine-Derived Microorganisms.Marine drugs · 2020Review
- Antibacterial Strategy againstACS medicinal chemistry letters · 2019Article
- Searching for potent and specific antibiotics against pathogenic Helicobacter and Campylobacter strains.Journal of industrial microbiology & biotechnology · 2019Review
- Article
- Aplasmomycin and boromycin are specific inhibitors of the futalosine pathway.The Journal of antibiotics · 2018Article
- Development and validation of an updated computational model of Streptomyces coelicolor primary and secondary metabolism.BMC genomics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28246380What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.